Latest Commercialisation News

Page 39 of 188
Archer Materials has progressed its Biochip program by completing the alpha prototype and Stage 1 project with IMEC, now advancing to develop a beta prototype suitable for external use and clinical validation.
Sophie Babbage
Sophie Babbage
7 Apr 2026
Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.
Ada Torres
Ada Torres
7 Apr 2026
Weebit Nano Ltd (ASX: WBT) has opened a non-underwritten Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 worth of shares at A$4.05 each. The company aims to raise up to A$15 million to support the commercialisation of its Resistive RAM (ReRAM) technology.
Sophie Babbage
Sophie Babbage
7 Apr 2026
BluGlass Limited (ASX: BLG) has entered a A$1.3 million strategic collaboration with a Fortune 500 global data storage company to advance photonics research using its proprietary visible laser technology.
Sophie Babbage
Sophie Babbage
7 Apr 2026
Nexsen Limited (ASX:NXN) has completed its Stage 1 ISO 13485 audit, confirming its Quality Management System (QMS) supports clinical validation and regulatory submissions for its diagnostic products, including StrepSure®. The company is progressing toward full certification and alignment with MDSAP requirements to facilitate global market access.
Ada Torres
Ada Torres
7 Apr 2026
Noble Helium has raised $12 million through a strongly supported institutional placement to fund its North Rukwa helium exploration in Tanzania, responding to tightening global helium supplies.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Tamboran Resources reports robust and stable gas production from its Shenandoah South 6H well, marking a key milestone ahead of planned gas sales in late 2026.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.
Victor Sage
Victor Sage
2 Apr 2026
Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.
Sophie Babbage
Sophie Babbage
2 Apr 2026
Pure Resources Limited has entered a legally binding R&D collaboration with Rice University to develop cutting-edge carbon nanotube fibre thermal management systems using graphite from its Garnet Hills Project. The partnership includes joint intellectual property ownership and a planned $3 million equity placement to fund exploration and downstream initiatives.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.
Ada Torres
Ada Torres
1 Apr 2026
Charger Metals NL advances its lithium and gold exploration with an expanded maiden resource at Medcalf and a striking high-grade gold discovery at Xmas. The company’s projects benefit from strong commodity prices and strategic locations in Australia’s premier mining jurisdictions.
Maxwell Dee
Maxwell Dee
1 Apr 2026